{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:31:37Z","timestamp":1772843497308,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R37 GM076343"],"award-info":[{"award-number":["R37 GM076343"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM007767"],"award-info":[{"award-number":["T32 GM007767"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jbc.2025.110529","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T23:19:45Z","timestamp":1753744785000},"page":"110529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytochrome P450 2W1: Identification of new inhibitors, active site ligands, and pharmacophores"],"prefix":"10.1016","volume":"301","author":[{"given":"Elyse K.","family":"Frydendall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily E.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110529_bib1","series-title":"Colon Cancer Specific Cytochrome P450 2W1: Polymorphism, Membrane Topology and Endogenous Roles in Development Doctoral Degree, Karolinska Institutet","author":"Guo","year":"2016"},{"key":"10.1016\/j.jbc.2025.110529_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122820","article-title":"Developmental regulation and induction of cytochrome P450 2W1, an enzyme expressed in colon tumors","volume":"10","author":"Choong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.110529_bib3","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1007\/s13277-014-2023-9","article-title":"Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour. Biol."},{"key":"10.1016\/j.jbc.2025.110529_bib4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3109\/0284186X.2014.887224","article-title":"The expression of CYP2W1 in colorectal primary tumors, corresponding lymph node metastases and liver metastases","volume":"53","author":"Stenstedt","year":"2014","journal-title":"Acta Oncol."},{"key":"10.1016\/j.jbc.2025.110529_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98217-z","article-title":"Cytochrome P450 isoforms 1A1, 1B1 and 2W1 as targets for therapeutic intervention in head and neck cancer","volume":"11","author":"Presa","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.110529_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/cjp2.291","article-title":"CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer","volume":"8","author":"Aiyappa-Maudsley","year":"2022","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.jbc.2025.110529_bib7","series-title":"Cancer Facts & Figures 2024","author":"Society","year":"2024"},{"key":"10.1016\/j.jbc.2025.110529_bib8","first-page":"3869","article-title":"The expression of CYP2W1: a prognostic marker in colon cancer","volume":"32","author":"Stenstedt","year":"2012","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.jbc.2025.110529_bib9","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1021\/jm4000209","article-title":"Re-engineering of the duocarmycin structural architecture enables bioprecursor development targeting CYP1A1 and CYP2W1 for biological activity","volume":"56","author":"Sheldrake","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2025.110529_bib10","doi-asserted-by":"crossref","first-page":"15391","DOI":"10.1021\/ja075398e","article-title":"A unique class of duocarmycin and CC-1065 analogues subject to reductive activation","volume":"129","author":"Jin","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2025.110529_bib11","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.drudis.2021.06.012","article-title":"Duocarmycin-based antibody-drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: pharmaceutical strategy and clinical progress","volume":"26","author":"Yao","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jbc.2025.110529_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/jmbi.1997.1223","article-title":"High resolution solution structure of a DNA duplex alkylated by the antitumor agent duocarmycin SA","volume":"272","author":"Eis","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2025.110529_bib13","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0040-4039(00)60376-3","article-title":"A novel guanine N3 alkylation by antitumor antibiotic duocarmycin A","volume":"34","author":"Sugiyama","year":"1993","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jbc.2025.110529_bib14","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1158\/1078-0432.CCR-13-0238","article-title":"Colon cancer-specific cytochrome P450 2W1 converts duocarmycin analogues into potent tumor cytotoxins","volume":"19","author":"Travica","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2025.110529_bib15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/acs.chemrestox.8b00413","article-title":"Highly variable expression of CYP1A1 in human liver and impact on pharmacokinetics of riociguat and granisetron in humans","volume":"32","author":"Lang","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jbc.2025.110529_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/dmd.121.000642","article-title":"Cytochrome P450 binding and bioactivation of tumor-targeted duocarmycin agents","volume":"50","author":"Bart","year":"2022","journal-title":"Drug Metab. Dispos"},{"key":"10.1016\/j.jbc.2025.110529_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbrc.2006.04.080","article-title":"Enzymatic properties of human CYP2W1 expressed in Escherichia coli","volume":"345","author":"Yoshioka","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2025.110529_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1124\/dmd.116.069633","article-title":"Catalytic activities of tumor-specific human cytochrome P450 CYP2W1 towards endogenous substrates","volume":"44","author":"Zhao","year":"2016","journal-title":"Drug Metab. Dispos"},{"key":"10.1016\/j.jbc.2025.110529_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbrc.2005.12.200","article-title":"Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1","volume":"341","author":"Karlgren","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2025.110529_bib20","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1194\/jlr.M027185","article-title":"Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids","volume":"53","author":"Xiao","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jbc.2025.110529_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/mol.110.065045","article-title":"Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1","volume":"78","author":"Nishida","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2025.110529_bib22","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1158\/1535-7163.MCT-11-0391","article-title":"CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells","volume":"10","author":"Tan","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2025.110529_bib23","doi-asserted-by":"crossref","first-page":"19201","DOI":"10.1074\/jbc.RA118.005588","article-title":"Structures of human cytochrome P450 1A1 with bergamottin and erlotinib reveal active-site modifications for binding of diverse ligands","volume":"293","author":"Bart","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110529_bib24","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0090-9556(24)15228-2","article-title":"Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells","volume":"27","author":"Lanza","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jbc.2025.110529_bib25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/clpt.1985.235","article-title":"Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation","volume":"38","author":"Schmid","year":"1985","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2025.110529_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/bbrc.1999.1702","article-title":"Formation of indigo by recombinant mammalian cytochrome P450","volume":"265","author":"Gillam","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2025.110529_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004850-200015040-00007","article-title":"Low dosage of levomepromazine did not increase plasma concentrations of fluvoxamine","volume":"15","author":"Yoshimura","year":"2000","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jbc.2025.110529_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1067\/mcp.2003.28","article-title":"Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers","volume":"73","author":"Skinner","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2025.110529_bib29","first-page":"970","article-title":"In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)- and S(-)-carvedilol","volume":"25","author":"Oldham","year":"1997","journal-title":"Drug Metab. Dispos"},{"key":"10.1016\/j.jbc.2025.110529_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/dmd.104.002766","article-title":"Selective inhibition of human cytochrome P4502C8 by montelukast","volume":"33","author":"Walsky","year":"2005","journal-title":"Drug Metab. Dispos"},{"key":"10.1016\/j.jbc.2025.110529_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107799","article-title":"Development of a high throughput cytochrome P450-ligand binding assay","volume":"300","author":"Frydendall","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110529_bib32","article-title":"Pyridine-containing substrate analogs are restricted from accessing the human cytochrome P450 8B1 active site by tryptophan 281","volume":"299","author":"Liu","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110529_bib33","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1074\/jbc.M609589200","article-title":"Cooperativity in cytochrome P450 3A4: linkages in substrate binding, spin state, uncoupling, and product formation","volume":"282","author":"Denisov","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110529_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0169-409X(02)00009-1","article-title":"Pharmacophore modeling of cytochromes P450","volume":"54","author":"de Groot","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jbc.2025.110529_bib35","doi-asserted-by":"crossref","first-page":"12932","DOI":"10.1074\/jbc.M113.452953","article-title":"Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism","volume":"288","author":"Walsh","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110529_bib36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1124\/dmd.119.089607","article-title":"Human cytochrome P450 1A1 adapts active site for atypical nonplanar substrate","volume":"48","author":"Bart","year":"2020","journal-title":"Drug Metab. Dispos"},{"key":"10.1016\/j.jbc.2025.110529_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.abb.2010.12.008","article-title":"Spectroscopic features of cytochrome P450 reaction intermediates","volume":"507","author":"Luthra","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jbc.2025.110529_bib38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0006-3002(63)91015-1","article-title":"Fractional solubilization of haemoproteins and partial purification of carbon monoxide-binding cytochrome from liver microsomes","volume":"71","author":"Omura","year":"1963","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2025.110529_bib39","doi-asserted-by":"crossref","first-page":"20818","DOI":"10.1074\/jbc.RA117.000220","article-title":"Structural and functional effects of cytochrome b5 interactions with human cytochrome P450 enzymes","volume":"292","author":"Bart","year":"2017","journal-title":"J. Biol. Chem."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825023804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825023804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:39:00Z","timestamp":1772807940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825023804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0021925825023804"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110529","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytochrome P450 2W1: Identification of new inhibitors, active site ligands, and pharmacophores","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110529"}}